Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01661205 · ClinicalTrials.gov registry record · NA
Dual Epicardial Endocardial Persistent Atrial Fibrillation(AF) Study (Staged DEEP)
A NA study, sponsored by AtriCure.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT01661205 is a NA study that has completed, run by AtriCure. The registered enrollment target is 30 participants.
The verdict
NCT01661205, a NA study, has completed, sponsored by AtriCure.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the safety and technical feasibility of treating subjects with Persistent Atrial Fibrillation or Longstanding Persistent Atrial Fibrillation in a minimally invasive thoracoscopic ablation procedure utilizing the AtriCure Bipolar System, with mapping and additional lesion creation/ gap closure (as needed) provided by currently approved catheter technology, when the epicardial and endocardial phases are performed in a staged manner within 1-10 days apart, during the same hospitalization.
Interventions
- DEVICE Ablation procedure staged catheter ablation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2012-08 |
| Est. Completion | 2015-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01661205
The ClinicalTrials.gov registry entry for NCT01661205 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AtriCure, which has 23 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ablation procedure staged catheter ablation is the first listed.
NCT01661205 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01661205 about?
NCT01661205 is a clinical study titled "Dual Epicardial Endocardial Persistent Atrial Fibrillation(AF) Study (Staged DEEP)". The purpose of this study is to assess the safety and technical feasibility of treating subjects with Persistent Atrial Fibrillation or Longstanding Persistent Atrial Fibrillation in a minimally invasive thoracoscopic ablation procedure utilizing the AtriCure Bipolar System, with mapping and additio...
What is the current status of trial NCT01661205?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2012-08. Estimated completion is 2015-12.
What interventions are being tested in trial NCT01661205?
The interventions under investigation include: Ablation procedure staged catheter ablation (DEVICE).
Who is sponsoring clinical trial NCT01661205?
This trial is sponsored by AtriCure, which has 23 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.